莱博雷生说明书,医保,价格,疗效,副作用

Lemborexant is a new insomnia treatment drug developed by Japanese company Eisai, with the trade name Dayvigo. As a dual orexin receptor antagonist, this drug improves insomnia symptoms by regulating the sleep-wake cycle and is suitable for patients with difficulty falling asleep and maintaining sleep. The following will introduce in detail the medical insurance situation, price information, treatment effects and possible side effects of this drug.

Lebrasin’s medical insurance situation

Understanding the medical insurance coverage is of great significance to the planning of patient treatment costs.

International medical insurance coverage

In the United States, Lebrasin has been included in some commercial insurance plans, and the reimbursement rate varies depending on the type of insurance. Japan's National Health Insurance can cover 70% of the cost of the drug, and patients pay 30% out of pocket.

Current status of domestic medical insurance

This drug has not yet been marketed in China, so it is not included in the Chinese medical insurance catalog. If domestic patients need to use it, they need to pay for it in full at their own expense.

As the drug is approved in more countries around the world, medical insurance coverage may gradually expand. Patients can regularly check local medical insurance policy updates.

Lebraxen price information

The price of Lebraxen varies depending on the specifications and purchasing area. Understanding this information can help patients make a budget.

Specifications and Price

Lebrasant is developed and produced by Japan Eisai Company. The price of 2.5 mg specification is about US$77 per box; the price of 5 mg specification of 100 tablets is about US$117 per box; the price of 10 mg specification is about US$165 per box. Large-sized packaging units are cheaper and suitable for long-term medication patients.

Influence of purchase channels

Prices in regular hospital pharmacies are relatively stable. Overseas medical treatment and overseas purchase of medicines may incur additional shipping costs and tariffs, increasing the total cost by 20%-30%.

Efficacy and Side Effects of Lebraxen

Evaluating the therapeutic effect and potential adverse reactions of Lebraxen is crucial for rational drug use.

Clinical efficacy

Research shows that Leborexen can shorten the time to fall asleep by about 20 minutes and reduce the number of nighttime awakenings. About 70% of patients reported significant improvement in sleep quality, with low residual effects the next day. Lebraxen can inhibit the wake-promoting effect of orexin, reduce wake signals, increase sleepiness, and help restore normal sleep rhythm.

Common side effects

Drowsiness, headache, fatigue and other reactions may occur after taking leborexan, with an incidence rate of about 10-15%. A few patients report abnormal dreams or sleep behavior disorders, usually to a mild degree.

Elderly patients and those with hepatic insufficiency need to adjust the dose of Leborexen. Pregnant women, lactating women and patients with severe liver damage are contraindicated. In addition, you should avoid drinking alcohol and engaging in activities that require high alertness while taking the drug.